Abstract
During the past several years, several important findings which may play a role in the degeneration of nigral cell in Parkinson’s disease (PD) have been disclosed (Table 1). In this review, we will critically discuss the significance and implications of those findings including the question as to whether those findings are the primary defects or the secondary effects of an as yet undiscovered primary abnormality in PD. In Parkinson’s disease, we cannot dismiss secondary abnormalities as they may interfere with the regenerative and restorative processes, and may contribute to the progression of the disease. We would like to start our discussion with iron accumulation in Parkinson’s disease.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Collins, M.A., and Neafsey, E., 1985, ß-Carboline analogues of N-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP): endogenous factors underlying idiopathic parkinsonism? Neurosci. Lett. 55: 179–184.
Corral-Debrinski, M., Horton, T., Lou, M.T., Shoffner, J.M., Beal, M.F., and Wallace, D., 1992, Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age, Nature Genetics, 2: 324–329.
Dexter, D.T., Carter, C.J., Wells, F.R., Javoy-Agid, F., Agid, Y., Lees, A., Jenner, P., and Marsden, C.D., 1989, Basal lipid peroxidation in substantia nigra is increased in Parkinson’s disease, J. Neurochem. 52: 381–389.
Halliwell, B., 1989, Oxidants and the central nervous system: some fundamental questions, Acta Neurol. Scand. 126: 23–33.
Hattori, N., Tanaka, M., Ozawa, T., and Mizuno, Y., 1991, Immunohistochemical studies on Complexes I, II, III, and IV of mitochondria in Parkinson’s disease, Ann. Neurol. 30: 563–571.
Ikebe, S., Tanaka, M., Ohno, K., Sato, W., Hattori, K., Kondo, T., Mizuno, Y., and Ozawa, T., 1990, Increase of deleted mitochondrial DNA in the striatum in Parkinson’s disease and senescence, Biochem. Biophys. Res. Commun. 170: 1044–1048.
Ikebe, S., Hattori, N., Mizuno, Y., Tanaka, M., and Ozawa, T., 1992, Point mutations of mitochondrial DNA in Parkinson’s disease, Abst. Mov. Disord. 7, Supp1. 1: 71.
Jenner, P., Dexter, D.T., Sian, J., Schapira, A.H.V., and Marsden, C.D., 1992, Oxidative stress as a cause of nigral cell death in Parkinson’s disease and incidental Lewy body disease, Ann. Neurol. 32: S82 - S87.
Kurth, J.H., Kurth, M.C., Poduslo, S.E., and Schwankhaus, J.D., 1993, Association of a monoamine oxidase B allele with Parkinson’s disease, Ann. Neurol. 33: 368–372.
Lestienne, P., Nelson, J., Riederer, P., Jellinger, K., and Reichmann, H., 1990, Normal mitochondrial genome in brain from patients with Parkinson’s disease and complex I defect, J. Neurochem. 55: 1810–1812.
Linnane, A.W., Marzuki, S., Ozawa, T., and Tanaka, M.,1989, Mitochondria) DNA mutations as an important contributor to ageing and degenerative diseases, Lancet 1: 642–645.
Marttila, R.J., Lorentz, H., and Rinne, U.K., 1988, Oxygen toxicity protecting enzymes in Parkinson’s disease: increase of superoxide dismutase-like activity in the substantia nigra and basal nucleus, J. Neurol. Sci. 86: 321–331.
Mizuno, Y., Ohta, S., Tanaka, M., Takamiya, S., Suzuki, K., Sato, T., Oya, H., Ozawa, T., and Kagawa, Y., 1989, Deficiencies in Complex I subunits of the respiratory chain in Parkinson’s disease, Biochem. Biophys. Res. Commun. 163: 1450–1455.
Mizuno, Y., Matuda, S., Yoshino, H., Mori, H., Hattori, N., and Ikebe, S., 1993, An immuno-histochemic al study on a-ketoglutarate dehydrogenase complex in Parkinson’s disease. Ann. Neurol., in press.
Mochizuki, H., Nishi, K., and Mizuno, Y., 1993, Iron-melanin complex is toxic to dopaminergic neurons in a nigrostriatal co-culture, Neurodegeneration 2: 1–7.
Moll, G., Moll, R, Riederer, P., Gsell, W., Heinsen, H., and Denney, R.M., 1990, Immunofluorescence cytochemistry on thin frozen sections of human substantia nigra for staining of monoamine oxidase A and monoamine oxidase B: a pilot study, J. Neural. Transm. Suppl. 32: 67–77.
Nagatsu, T., and Yoshida, M.,1988, An endogenous substance of the brain, tetrahydroisoquinoline, produces parkinsonism in primates with decreased dopamine, tyrosine hydroxylase and biopterine in the nigrostriatal regions, Neurosci. Lett. 87: 178–182.
Naoi, M., Takahashi, T., Parvez, H., Kabeya, R., Taguchi, E., Yamaguchi, K., Hirata, Y., Minami, M., and Nagatsu, Y., 1989, N-methylisoquinolinium ion as an inhibitor of tyrosine hydroxylase, aromatic Lamino acid decarboxylase and monoamine oxidase, Neurochem. Int. 15: 315–320.
Perry, T.L., and Yong, V.W., 1986, Idiopathic Parkinson’s disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients, Neurosci. Lett. 67: 269–274.
Philbert, M.A., Beiswanger, C.M., Waters, D.K., Reuhl, K.R., and Lowndes, H.E., 1991, Cellular and regional distributions of reduced glutathione in the nervous system of the rat: histochemical localization by mercury orange and o-phthalaldehyde-induced histofluorescence, Toxicol. App. Pharmacol. 107: 215–227.
Riederer, P., Sofic, E., Rausch, W.D., Schmidt, B., Reynolds, G.P., Jellinger, K., and Youdim, M.B.H., 1989, Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains, J. Neurochem. 52: 515–520.
Saggu, H., Cooksey, J., Dexter, D., Wells, F.R., Lees, A., Jenner, P., and Marsden, C.D., 1989, A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra, J. Neurochem. 53: 692–697.
Sandler, M., Carter, S.B., Hunter, K.R., and Stern, G.M., 1973, Tetrahydroisoquinoline alkaloids: in vivo metabolites of L-dopa in man, Nature 241: 439–443.
Schapira, A.H.V., Cooper, J.M., Dexter, D., Jenner, P., Clark, J.B., and Marsden, C.D., 1989, Mitochondrial complex I deficiency in Parkinson’s disease, Lancet 1: 1269.
Schapira, A.H.V., Holt, U., Sweeney, M., Harding, A.E., Jenner, P., and Marsden, C.D.,1990, Mitochondrial DNA analysis in Parkinson’s disease, Mov. Disord. 5: 294–297.
Shoffner, J.M., Brown, M.D., Torroni, A., Lott, M.T., Cabell, M.F., Mirra, S.S., Beal, M.F., Yang, C.C., Gearing, M., Salvo, R., Watts, R.L., Juncos, J.L., Hansen L.A., Crain, B.J., Fayad, M., Reckord, C.L., and Wallace, D.C., 1993, Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients, Genomics 17: 171–184.
Smith, C.A., Gough, A.C., Leigh, P.N., Summers, B.A., Harding, A.E., Maranganore, D.M., Sturman, S.G., Schapira, A.V., Williams, A.C., Spun, N.K., and Wolf, C.R., 1992, Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson’s disease, Lancet 339: 1375–1377.
Soong, K., Hinton, D.R., Cortopassi, G., and Arnheim, N., 1992, Mosaicism for a specific somatic mitochondrial DNA mutation in adult human brain, Nature Genetics 2: 318–323.
Suzuki, K., Mizuno, Y., and Yoshida, M., 1990, Inhibition of mitochondrial respiration by 1,2,3,4tetrahydroisoquinoline-like endogenous alkaloids in mouse brain, Neurochem. Res. 15: 705–710.
Suzuki, K., Mizuno, Y., Yamauchi, Y., Nagatsu, T., and Yoshida, M., 1992, Selective inhibition of complex I by N-methylisoquinolinium ion and N-methyl-1,2,3,4-tetrahydroisoquinoline in isolated mitochondria prepared from mouse brain, J.Neurol. Sci. 109: 219–223.
Youdim, M.B.H., Ben-Shachar, D., and Riederer, P. 1989, Is Parkinson’s disease a progressive siderosis of substantia nigra resulting in ion and melanin induced neurodegeneration? Acta Neurol. Scand., 126: 47–54.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer Science+Business Media New York
About this chapter
Cite this chapter
Mizuno, Y. et al. (1995). Pathogenesis of Nigral Cell Death in Parkinson’s Disease. In: Hanin, I., Yoshida, M., Fisher, A. (eds) Alzheimer’s and Parkinson’s Diseases. Advances in Behavioral Biology, vol 44. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9145-7_32
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9145-7_32
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9147-1
Online ISBN: 978-1-4757-9145-7
eBook Packages: Springer Book Archive